OMERS ADMINISTRATION Corp bought a new position in shares of Centene Corporation (NYSE:CNC – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 27,222 shares of the company’s stock, valued at approximately $1,747,000.
A number of other institutional investors also recently modified their holdings of the company. 180 Wealth Advisors LLC boosted its holdings in shares of Centene by 3.1% during the 1st quarter. 180 Wealth Advisors LLC now owns 6,683 shares of the company’s stock worth $219,000 after buying an additional 199 shares during the period. Summitry LLC raised its holdings in Centene by 1.1% in the 1st quarter. Summitry LLC now owns 23,925 shares of the company’s stock worth $783,000 after acquiring an additional 253 shares during the period. GAMMA Investing LLC boosted its holdings in Centene by 2.4% during the second quarter. GAMMA Investing LLC now owns 10,674 shares of the company’s stock valued at $685,000 after acquiring an additional 253 shares during the period. Kestra Advisory Services LLC grew its position in shares of Centene by 0.5% in the fourth quarter. Kestra Advisory Services LLC now owns 52,602 shares of the company’s stock valued at $2,165,000 after purchasing an additional 264 shares during the last quarter. Finally, CX Institutional increased its stake in shares of Centene by 3.1% in the second quarter. CX Institutional now owns 8,999 shares of the company’s stock worth $578,000 after purchasing an additional 269 shares during the period. Institutional investors own 93.63% of the company’s stock.
Insider Transactions at Centene
In related news, General Counsel Christopher Koster sold 47,603 shares of the stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $65.36, for a total value of $3,111,332.08. Following the completion of the transaction, the general counsel owned 305,354 shares of the company’s stock, valued at $19,957,937.44. This represents a 13.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.37% of the stock is owned by company insiders.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on CNC
Centene Price Performance
Shares of NYSE:CNC opened at $65.35 on Thursday. The firm has a market capitalization of $32.28 billion, a PE ratio of -6.26, a PEG ratio of 0.35 and a beta of 1.08. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.71. Centene Corporation has a 1-year low of $28.24 and a 1-year high of $69.36. The business’s 50 day moving average is $65.17 and its 200-day moving average is $52.98.
Centene (NYSE:CNC – Get Free Report) last issued its earnings results on Monday, July 27th. The company reported $2.51 EPS for the quarter, topping the consensus estimate of $1.09 by $1.42. Centene had a positive return on equity of 12.12% and a negative net margin of 2.51%.The firm had revenue of $53.58 billion during the quarter, compared to analysts’ expectations of $47.64 billion. During the same period last year, the business earned ($0.16) earnings per share. Centene’s quarterly revenue was up 9.9% compared to the same quarter last year. Sell-side analysts predict that Centene Corporation will post 4.89 earnings per share for the current year.
About Centene
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Further Reading
- Five stocks we like better than Centene
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
